UNSPSC 51131827: Eltrombopag olamine

This classification denotes an agent affecting blood and body fluid C25H22N4O4.2C2H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U07F515LG, chemically known as (1,1'-biphenyl)-3-carboxylic acid, 3'-((2z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene)hydrazino)-2'-hydroxy-, compound with 2-aminoethanol (1:2), but more generally known as eltrombopag olamine, which bears US NIH Compound Identifier 9915926.

UNSPSC 51131827 Eltrombopag olamine is a Commodity code nominally identifying a specific pharmaceutical product, yet the most recent state and local solicitation activity tagged under this code shows no relevant procurement. Sourcewell, the State of Minnesota's cooperative purchasing vehicle, posted RFP #061626 in May 2026 seeking Law Enforcement Equipment on behalf of participating counties and public entities across multiple states — a scope entirely unrelated to pharmaceutical procurement. The mismatch suggests either a coding error in how the opportunity was indexed or that this Commodity code sees no current state and local procurement activity for its stated product.

The single recent record in the activity block does not reflect actual purchasing under UNSPSC 51131827. Absent additional opportunities tied correctly to eltrombopag olamine procurement by state health departments, Medicaid agencies, state hospitals, or public health systems, this code presents no actionable business development signal at this time.